Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues

被引:15
作者
Bozkurt, Kemal Kursat [1 ]
Kapucuoglu, Nilgun [1 ]
机构
[1] Suleyman Demirel Univ, Fac Med, Dept Pathol, TR-32200 Isparta, Turkey
关键词
Breast cancer; ER alpha; ER beta; ER beta cx; Immunohistochemistry; ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA; WILD-TYPE; PROTEIN EXPRESSION; PROGNOSTIC-FACTORS; ENDOCRINE THERAPY; CANCER; TAMOXIFEN; RESPONSIVENESS; LOCALIZATION;
D O I
10.1016/j.prp.2011.12.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Estrogen receptor alpha (ER alpha) is a well-established prognostic marker in breast cancer. The role of estrogen receptor beta (ER beta) in breast cancers is still under investigation. We aimed to investigate the clinicopathological significance and immunohistochemical expression patterns of ER alpha, total ER beta (ER beta) and its spliced variant ER beta cx in normal breast, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). Our study population comprised 10 normal breasts, 26 DCISs and 44 IDCs. Immunohistochemical expression of these markers was investigated in sections of formalin-fixed, paraffin-embedded blocks by 2 observers. In invasive ductal carcinomas, ER beta expression had a significant positive correlation with ER alpha expression (p = 0.013), while ER beta cx expression was significantly associated with the presence of lymphovascular invasion (p = 0.046). There was a significant relationship between ER alpha expression and low histological grade (p < 0.0001). Similarly, ER alpha+/ER beta+ tumors (p = 0.004) and ER alpha+/ER beta cx+ tumors (p = 0.008) were significantly associated with low histological grade, too. ER alpha expression (p = 0.009), ER beta cx expression (p = 0.048) and ER alpha+/ER beta+ coexpression (p = 0.002) increased significantly in progression from normal breast to invasive ductal carcinoma. Expression of ER alpha correlates with less aggressive phenotypic features, and ER beta expression is positively correlated with ER alpha expression in breast cancer. ER beta cx is associated with aggressive features and can take part in the progression of invasive carcinoma. Increase in ER alpha+/ER beta+ coexpression, ER alpha expression and ER beta cx expression in breast cancer progression indicates an enhancement in ER expressions or an alteration in expression patterns of different ER variants during mammary carcinogenesis. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
[1]   Estrogen receptor α and β profiling in human breast cancer [J].
Balfe, P ;
McCann, A ;
McGoldrick, A ;
McAllister, K ;
Kennedy, M ;
Dervan, P ;
Kerin, MJ .
EJSO, 2004, 30 (05) :469-474
[2]  
Beatson GT., 1896, LANCET, V148, P104
[3]   ENDOGENOUS HORMONES AND BREAST-CANCER RISK [J].
BERNSTEIN, L ;
ROSS, RK .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :48-65
[4]   A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERβ in archival formalin-fixed paraffin embedded human breast tissue [J].
Carder, PJ ;
Murphy, CE ;
Dervan, P ;
Kennedy, M ;
McCann, A ;
Saunders, PTK ;
Shaaban, AM ;
Foster, CS ;
Witton, CJ ;
Bartlett, JMS ;
Walker, RA ;
Speirs, V .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (03) :287-293
[5]   A comparison of transcriptional activation by ERα and ERβ [J].
Cowley, SM ;
Parker, MG .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) :165-175
[6]  
Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606
[7]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[8]   Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern [J].
Enmark, E ;
Pelto-Huikko, M ;
Grandien, K ;
Lagercrantz, S ;
Lagercrantz, J ;
Fried, G ;
Nordenskjöld, M ;
Gustafsson, JÅ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4258-4265
[9]   Increased estrogen receptor βcx expression during mammary carcinogenesis [J].
Esslimani-Sahla, M ;
Kramar, A ;
Simony-Lafontaine, J ;
Warner, M ;
Gustafsson, JÅ ;
Rochefort, H .
CLINICAL CANCER RESEARCH, 2005, 11 (09) :3170-3174
[10]   Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer [J].
Esslimani-Sahla, M ;
Simony-Lafontaine, J ;
Kramar, A ;
Lavaill, R ;
Mollevi, C ;
Warner, M ;
Gustallsson, JÅ ;
Rochefort, H .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5769-5776